IRS2 and type 2 diabetes mellitus: As a corollary to menin-ARS2 complex repressing Irs2, a key player in regulating beta cell mass and function [35], the discovery of a small molecule that interferes with this binding may hold considerable promise for use in the treatment of type 2 diabetes.